Pseudodominant inheritance in paraplegin (SPG7)-associated CPEO-ataxia syndrome.

NeurogeneticsOct 28, 2026 (epub)
Case ReportNeurologyMedical GeneticsOpen access

Weber Liu, Serge Geara, Simon Rowe et al.

✦ AI-curated · Sources linked

Case in brief

A 47-year-old man presented with progressive external ophthalmoplegia, ptosis, gait disturbance and spasticity. Over ten years, he developed slowly progressive spastic ataxia with ocular motor involvement and neurogenic bladder. His mother and maternal aunt had similar features, including spasticity, ataxia, ptosis and external ophthalmoplegia. Testing found compound heterozygous pathogenic SPG7 variants in the man; his mother and aunt were homozygous for the canonical splice-site variant c.2182-2 A > G. His asymptomatic father carried the pathogenic p.(Ala510Val) missense variant, explaining the family’s pseudodominant pattern.

What made this case unusual

The family history appeared dominant despite SPG7-associated disease usually being autosomal recessive: affected relatives were homozygous for one variant, while the proband’s asymptomatic father carried another pathogenic variant.

Diagnostic / clinical pearl

A vertical pattern of affected relatives does not exclude an autosomal recessive disorder. Segregation analysis and comprehensive genomic testing can clarify apparent pseudodominance in SPG7-associated disease.

Why it matters

Recognising pseudodominant inheritance has implications for genetic counselling, family planning and cascade testing.

Source

Published in Neurogenetics. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Neurology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.